O'Neill A - Search Results

1

Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.

Grossman SA, O'Neill A, Grunnet M, Mehta M, Pearlman JL, Wagner H, Gilbert M, Newton HB, Hellman R; Eastern Cooperative Oncology Group. Grossman SA, et al. J Clin Oncol. 2003 Apr 15;21(8):1485-91. doi: 10.1200/JCO.2003.10.035. J Clin Oncol. 2003. PMID: 12697871 Clinical Trial.

2

Phase II trial of radiosurgery for one to three newly diagnosed brain metastases from renal cell carcinoma, melanoma, and sarcoma: an Eastern Cooperative Oncology Group study (E 6397).

Manon R, O'Neill A, Knisely J, Werner-Wasik M, Lazarus HM, Wagner H, Gilbert M, Mehta M; Eastern Cooperative Oncology Group. Manon R, et al. J Clin Oncol. 2005 Dec 1;23(34):8870-6. doi: 10.1200/JCO.2005.01.8747. J Clin Oncol. 2005. PMID: 16314647 Clinical Trial.

3

Preradiation Chemotherapy for Adult High-risk Medulloblastoma: A Trial of the ECOG-ACRIN Cancer Research Group (E4397).

Moots PL, O'Neill A, Londer H, Mehta M, Blumenthal DT, Barger GR, Grunnet ML, Grossman S, Gilbert MR, Schiff D. Moots PL, et al. Am J Clin Oncol. 2018 Jun;41(6):588-594. doi: 10.1097/COC.0000000000000326. Am J Clin Oncol. 2018. PMID: 27635620 Free PMC article. Clinical Trial.

4

Survival of patients with newly diagnosed glioblastoma multiforme treated with RSR13 and radiotherapy: results of a phase II new approaches to brain tumor therapy CNS consortium safety and efficacy study.

Kleinberg L, Grossman SA, Carson K, Lesser G, O'Neill A, Pearlman J, Phillips P, Herman T, Gerber M. Kleinberg L, et al. J Clin Oncol. 2002 Jul 15;20(14):3149-55. doi: 10.1200/JCO.2002.01.096. J Clin Oncol. 2002. PMID: 12118029 Clinical Trial.

5

A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: an Eastern Cooperative Oncology Group study (E2393).

Gilbert M, O'Neill A, Grossman S, Grunnet M, Mehta M, Jubelirer S, Hellman R. Gilbert M, et al. J Neurooncol. 2000 Apr;47(2):145-52. doi: 10.1023/a:1006402123397. J Neurooncol. 2000. PMID: 10982156 Clinical Trial.

6

Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial.

Robins HI, O'Neill A, Gilbert M, Olsen M, Sapiente R, Berkey B, Mehta M. Robins HI, et al. Cancer Chemother Pharmacol. 2008 Jul;62(2):227-33. doi: 10.1007/s00280-007-0596-3. Epub 2007 Sep 20. Cancer Chemother Pharmacol. 2008. PMID: 17882417 Free PMC article. Clinical Trial.

7

Correlation of tumor p53 and PCNA with response and survival of glioblastoma in patients treated with an ECOG protocol of pre-irradiation chemotherapy.

Grunnet ML, O'Neill A, Gilbert M, Hellman R. Grunnet ML, et al. Clin Neuropathol. 2000 Sep-Oct;19(5):230-4. Clin Neuropathol. 2000. PMID: 11048748

8

Chemoendocrine therapy for premenopausal women with axillary lymph node-positive, steroid hormone receptor-positive breast cancer: results from INT 0101 (E5188).

Davidson NE, O'Neill AM, Vukov AM, Osborne CK, Martino S, White DR, Abeloff MD. Davidson NE, et al. J Clin Oncol. 2005 Sep 1;23(25):5973-82. doi: 10.1200/JCO.2005.05.551. Epub 2005 Aug 8. J Clin Oncol. 2005. PMID: 16087950 Clinical Trial.

9

A pilot phase II trial of valspodar modulation of multidrug resistance to paclitaxel in the treatment of metastatic carcinoma of the breast (E1195): a trial of the Eastern Cooperative Oncology Group.

Carlson RW, O'Neill AM, Goldstein LJ, Sikic BI, Abramson N, Stewart JA, Davidson NE, Wood WC; Eastern Cooperative Oncology Group. Carlson RW, et al. Cancer Invest. 2006 Nov;24(7):677-81. doi: 10.1080/07357900600981349. Cancer Invest. 2006. PMID: 17118777 Clinical Trial.

10

Phase II study of rituximab given in conjunction with standard chemotherapy in primary central nervous system lymphoma (PCNSL): a trial of the ECOG-ACRIN cancer research group (E1F05).

Swinnen LJ, O'Neill A, Imus PH, Gujar S, Schiff D, Kleinberg LR, Advani RH, Dunbar EM, Moore D, Grossman SA. Swinnen LJ, et al. Oncotarget. 2017 Nov 6;9(1):766-773. doi: 10.18632/oncotarget.22332. eCollection 2018 Jan 2. Oncotarget. 2017. PMID: 29416652 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,029 results

Search Page

Filters